Rare diseases
Investigational molecules
Locations
Back to Greece116 clinical trials in Efkarpia, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GreeceStudy of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
GreeceLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GreeceA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
GreeceStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GreeceLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
GreeceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GreeceStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
GreeceStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
GreeceStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
GreecePhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
GreecePumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation
GreeceThe busiest research cities in the country
What the registry says about research in the country
Extensive trials focusing on hidradenitis suppurativa and atopic dermatitis, evaluating novel therapeutic approaches and treatment combinations to improve patient outcomes.
Multiple studies testing new biological therapies and their long-term safety profiles.
Research centered on lupus erythematosus and Sjögren's Disease, investigating targeted therapies to manage disease progression and symptoms.
Studies aim to evaluate new therapeutic agents for better disease control.
Innovative trials examining treatments for Type 2 Diabetes and obesity, with focus on cardiovascular outcomes and weight management.
Research comparing new therapeutic options against established treatments.
Advanced research in metastatic breast cancer and colorectal cancer, evaluating targeted therapies and combination treatments.
Focus on improving progression-free survival in advanced disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
